We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-6.65%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$28.8B
AUM Growth
-$2.23B
Cap. Flow
+$304M
Cap. Flow %
1.06%
Top 10 Hldgs %
35.81%
Holding
611
New
169
Increased
112
Reduced
248
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 23.32%
2 Technology 20.77%
3 Consumer Staples 14.27%
4 Consumer Discretionary 12.94%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPL
501
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$346K ﹤0.01%
+54,100
New +$428K
BCA
502
DELISTED
CORPBANCA SPONSORED ADR REPSTG (1-1,500)COM STK
BCA
$344K ﹤0.01%
+25,800
New +$375K
RDY icon
503
Dr. Reddy's Laboratories
RDY
$9.8B
$339K ﹤0.01%
+26,500
New +$329K
UNT
504
DELISTED
UNIT Corporation
UNT
$337K ﹤0.01%
+29,900
New +$509K
VOYA icon
505
Voya Financial
VOYA
$8.96B
$336K ﹤0.01%
+8,674
New +$381K
CAT icon
506
Caterpillar
CAT
$361B
$333K ﹤0.01%
+5,100
New +$390K
SCCO icon
507
Southern Copper
SCCO
$138B
$331K ﹤0.01%
13,376
-8,696
-39% -$221K
CEO
508
DELISTED
CNOOC Limited
CEO
$330K ﹤0.01%
3,200
AVGO icon
509
Broadcom
AVGO
$1.76T
$325K ﹤0.01%
26,000
-321,000
-93% -$4.06M
PLCE icon
510
Children's Place
PLCE
$53.8M
$323K ﹤0.01%
+5,600
New +$337K
BMY icon
511
Bristol-Myers Squibb
BMY
$129B
$320K ﹤0.01%
5,400
-2,010
-27% -$128K
LM
512
DELISTED
Legg Mason, Inc.
LM
$316K ﹤0.01%
7,600
-15,000
-66% -$695K
PKD
513
DELISTED
Parker Drilling Company
PKD
$314K ﹤0.01%
+7,960
New +$336K
AKAM icon
514
Akamai
AKAM
$15.6B
$312K ﹤0.01%
4,515
-179,967
-98% -$13M
NEE icon
515
NextEra Energy
NEE
$184B
$312K ﹤0.01%
+12,800
New +$325K
STBA icon
516
S&T Bancorp
STBA
$1.9B
$310K ﹤0.01%
+9,500
New +$291K
NBR icon
517
Nabors Industries
NBR
$1.17B
$300K ﹤0.01%
+634
New +$356K
ERF
518
DELISTED
Enerplus Corporation
ERF
$292K ﹤0.01%
60,300
-43,600
-42% -$277K
CMCSK
519
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$279K ﹤0.01%
+4,870
New +$279K
SYNT
520
DELISTED
Syntel Inc
SYNT
$275K ﹤0.01%
6,076
SBUX icon
521
Starbucks
SBUX
$119B
$273K ﹤0.01%
4,800
-14
-0.3% -$784
RTN
522
DELISTED
Raytheon Company
RTN
$273K ﹤0.01%
+2,500
New +$261K
NSIT icon
523
Insight Enterprises
NSIT
$3.85B
$271K ﹤0.01%
+10,500
New +$278K
DAL icon
524
Delta Air Lines
DAL
$56.7B
$270K ﹤0.01%
6,026
+273
+5% +$12.3K
TRMK icon
525
Trustmark
TRMK
$2.75B
$269K ﹤0.01%
+11,600
New +$275K

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2015 Portfolio in Review

As of Q3 2015, Grantham, Mayo, Van Otterloo & Co (GMO) held 611 positions worth $28.8B, down 7.2% from $31B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2015 filing shows 169 new, 112 increased, 248 reduced and 42 closed positions. Its largest new stake was Charter Communications: 3,884,492 shares worth $683M. The largest sale was Express Scripts Holding Company, an estimated $528M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2015 buy was Charter Communications: 3,884,492 shares worth $683M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Bausch Health in Q3 2015, an estimated $1.51B increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2015 reduction was Express Scripts Holding Company, cutting an estimated $528M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Check Point Software Technologies in Q3 2015, selling an estimated $155M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 36% of its $28.8B portfolio in Q3 2015.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 169 new positions and closed 42 in Q3 2015.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 7.2% quarter-over-quarter to $28.8B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2015, filed 13 Nov 2015.